-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Acorda Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2010 to 2023.
- Acorda Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending March 31, 2024 was 1.24M shares, unchanged year-over-year.
- Acorda Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 1.24M shares, a 22.8% increase from 2022.
- Acorda Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 1.01M shares, a 90.5% decline from 2021.
- Acorda Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 10.6M shares, a 31.4% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)